Takeda, Asia's largest pharma firm, expects full-year operating profit to increase by 8% to JPY150bn ($1.47bn) as recently implemented cost-efficiency measures kick in and new products boost sales figures.
written on 08.05.2014
Takeda, Asia's largest pharma firm, expects full-year operating profit to increase by 8% to JPY150bn ($1.47bn) as recently implemented cost-efficiency measures kick in and new products boost sales figures.
See our Cookie Privacy Policy Here